Qualigen Therapeutics Inc banner

Qualigen Therapeutics Inc
NASDAQ:QLGN

Watchlist Manager
Qualigen Therapeutics Inc Logo
Qualigen Therapeutics Inc
NASDAQ:QLGN
Watchlist
Price: 2.33 USD 0.3% Market Closed
Market Cap: $4.7m

Dividends

Qualigen Therapeutics Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Qualigen Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Qualigen Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

QLGN Price
Qualigen Therapeutics Inc

Annual Price Range
2.33
52w Low
1.67
52w High
6.01
Price Metrics
Average Annual Return -67.04%
Standard Deviation of Annual Returns 24.74%
Max Drawdown -100%
Shares Statistics
Market Capitalization 4.7m USD
Shares Outstanding 2 030 000
Percentage of Shares Shorted 18.84%

QLGN Return Decomposition
Main factors of price return

Stock Splits

QLGN's latest stock split occurred on Nov 5, 2024

The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.

Before the split, QLGN traded at 0.1011 per share. Afterward, the share price was about 5.08.

The adjusted shares began trading on Nov 5, 2024. This was QLGN's 4th stock split, following the previous one in Nov 23, 2022.

Pre-Split Price
5.055 0.1011
Post-Split Price
5.08
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett